Michele Maio

Researcher Next ID · RN-002618

Researcher · Medicine

Siena, Italy

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Cancer Immunotherapy and Biomarkers

CAR-T cell therapy research

Immunotherapy and Immune Responses

Melanoma and MAPK Pathways

Cutaneous Melanoma Detection and Management

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1412082
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103782
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1104621

No projects listed.